+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 60Years
All Genders
ID07678697

Comparing Two Laser Techniques Combined with Injection Sclerotherapy for Treating Reticular and Spider Veins Using the CLaCS Method

Led by Ain Shams University · Updated on 2026-07-01

80

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating two laser treatments combined with injection sclerotherapy for reticular veins and telangiectasias, common chronic venous disorders affecting many adults, especially women. The study compares the effectiveness and safety of NdYAG laser and diode laser using the Cryo-Laser and Cryo-Sclerotherapy CLaCS technique. This innovative method enhances vein visibility and targets feeder veins precisely while cooling the skin to reduce pain and protect the epidermis. Participants will receive either the NdYAG laser 1064 nm plus injection sclerotherapy or the diode laser 980 nm plus injection sclerotherapy. Both treatments use the CLaCS technique, which combines transdermal laser therapy, sclerotherapy injections, and skin cooling. The study is randomized with parallel groups to compare these two approaches. During the study, participants will be monitored for vein clearance, pain levels, patient satisfaction, complications, number of treatment sessions, and recurrence rates at 6 months after treatment. Evaluations will include clinical assessments and safety monitoring throughout the study period. The total participation duration lasts until 6 months post-treatment to observe outcomes and possible recurrences.

CONDITIONS

Brief Title

Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS Technique

Research Team

M

Mohamed A Hagag, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here